Delays in breast cancer surgery due to the COVID-19 pandemic could cost 2,797 additional deaths in the U.S. over the next decade, according to a Kantar Health analysis. Such treatment delays also place patients at a higher risk of metastasis, or cancer spread, potentially increasing healthcare costs in the U.S. by an estimated $376 million over the next 10 years, the analysis suggests. “The effects of the pandemic will be felt deeply in many disease…
You must be logged in to read/download the full post.
The post COVID-19 Surgery Delays May Mean 2,700 More Breast Cancer Deaths Within 10 Years appeared first on BioNewsFeeds.